Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Development of a Short Version of MSQOL-54 Using Factor Analysis and Item Response Theory.
Patients with neuromyelitis optica have a more severe disease than patients with relapsingremitting multiple sclerosis, including higher risk of dying of a demyelinating disease.
Multiple sclerosis incidence associated with the soil lead and arsenic concentrations in taiwan.
A critical role for interleukin-1β in the progression of autoimmune diseases.
Growth hormone response to clonidine administration for evaluation of autonomic dysfunction in multiple sclerosis patients.
Dimethyl fumarate for treatment of multiple sclerosis: mechanism of action, effectiveness, and side effects.
Clinico-radiologic profile of spinal cord multiple sclerosis in adults.
Frequent Infection of Neurons by SV40 Virus in SIV-Infected Macaque Monkeys with Progressive Multifocal Leukoencephalopathy and Meningoencephalitis.
Fatty fish intake is associated with decreased occurrence of multiple sclerosis.
Cutting-edge of advanced MRI for demyelinating diseases.
Myelin basic protein induces neuron-specific toxicity by directly damaging the neuronal plasma membrane.
Development of a cross-cultural item bank for measuring quality of life related to mental health in multiple sclerosis patients.
Antibody biomarkers in CNS demyelinating diseases - a long and winding road.
Cognitive and patient-reported outcomes in adults with pediatric-onset multiple sclerosis.
Tau protein levels in the cerebrospinal fluid of the patients with multiple sclerosis in an attack period: Low levels of tau protein may have significance, too.
The habenula and iron metabolism in cerebral mouse models of multiple sclerosis.
The gut-brain axis: interactions between Helicobacter pylori and enteric and central nervous systems.
Multiple sclerosis: relapses, resource use, and costs.
Progressive multiple sclerosis cerebrospinal fluid induces inflammatory demyelination, axonal loss, and astrogliosis in mice.
Determinants of disability in multiple sclerosis: an immunological and MRI study.
Pain in neuromyelitis optica-prevalence, pathogenesis and therapy.
Generic quality of life burden of multiple sclerosis as compared to other debilitating chronic conditions.
White matter disease: Aquaporin-4 antibody-positive patients may not always fulfil the clinical criteria for neuromyelitis optica.
Trichloropropane and dichlorohydrin associated with painful peripheral neurotoxicity.
The contribution of optical coherence tomography in neurodegenerative diseases.
Pages
« first
‹ previous
…
641
642
643
644
645
646
647
648
649
…
next ›
last »